Article in Journal of virology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
7 authors.
Abraham J KandathilDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.ORCID 0000-0002-9038-134X
Steven J ClipmanDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.ORCID 0000-0002-2366-8420
Raghavendran AnantharamDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Dylan DuchenDepartment of Pathology, Yale University School of Medicine, New Haven, Connecticut, USA.
Andrea L CoxDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
H Benjamin LarmanInstitute for Cell Engineering, Division of Immunology, Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
David L ThomasDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Funding
The development and pre-clinical assessment of novel HCV vaccines to generate T and B cell immunityU19AI159822 · NIAID · JOHNS HOPKINS UNIVERSITY · PI BJORKMAN, PAMELA J · 2021 to 2025
$14.4M
Leveraging the plasma virome as a biological indicator of HIV risk and transmission networks among people who inject drugsR01DA058567 · NIDA · JOHNS HOPKINS UNIVERSITY · PI Steven J. Clipman, Abraham Kandathil · 2023 to 2026
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Antibody-mediated control of anellovirus infection: evidence from people who inject drugs. · full record | OpenQuestion